These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22250646)

  • 1. Endothelin-1 and endothelin a receptor immunoreactivity is increased in patients with diabetic nephropathy.
    Zanatta CM; Veronese FV; Loreto Mda S; Sortica DA; Carpio VN; Eldeweiss MI; da Silva VD; Lopes TG; Gross JL; Canani LH
    Ren Fail; 2012; 34(3):308-15. PubMed ID: 22250646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies.
    Drakopoulos A; Goumenos DS; Vlachojannis JG; Tsakas S
    Ren Fail; 2006; 28(6):461-7. PubMed ID: 16928614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
    Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
    Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of the compound of traditional Chinese drugs on gene expression of renal endothelin and its receptor of experimental diabetic nephropathy].
    Wan YG; Wan M; Fan Y; Gu LB; Li M
    Zhongguo Zhong Yao Za Zhi; 2003 Feb; 28(2):159-62. PubMed ID: 15015294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
    Mezzano S; Aros C; Droguett A; Burgos ME; Ardiles L; Flores C; Schneider H; Ruiz-Ortega M; Egido J
    Nephrol Dial Transplant; 2004 Oct; 19(10):2505-12. PubMed ID: 15280531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.
    Lindenmeyer MT; Kretzler M; Boucherot A; Berra S; Yasuda Y; Henger A; Eichinger F; Gaiser S; Schmid H; Rastaldi MP; Schrier RW; Schlöndorff D; Cohen CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1765-76. PubMed ID: 17475821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
    Wu CC; Chen JS; Lu KC; Chen CC; Lin SH; Chu P; Sytwu HK; Lin YF
    Clin Chim Acta; 2010 May; 411(9-10):700-4. PubMed ID: 20138168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen type VIII expression in human diabetic nephropathy.
    Gerth J; Cohen CD; Hopfer U; Lindenmeyer MT; Sommer M; Gröne HJ; Wolf G
    Eur J Clin Invest; 2007 Oct; 37(10):767-73. PubMed ID: 17888087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.
    Lin YL; Peng SJ; Ferng SH; Tzen CY; Yang CS
    Int J Clin Pract; 2009 Aug; 63(8):1167-76. PubMed ID: 18422591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy results from increased expression and cellular release of tissue transglutaminase.
    El Nahas AM; Abo-Zenah H; Skill NJ; Bex S; Wild G; Griffin M; Johnson TS
    Nephron Clin Pract; 2004; 97(3):c108-17. PubMed ID: 15292688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of selectins in kidneys of patients with diabetic nephropathy.
    Hirata K; Shikata K; Matsuda M; Akiyama K; Sugimoto H; Kushiro M; Makino H
    Diabetologia; 1998 Feb; 41(2):185-92. PubMed ID: 9498652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal histological lesions in patients with type II diabetes mellitus].
    Castellano I; Covarsí A; Novillo R; Gómez-Martino JR; Ferrando L
    Nefrologia; 2002; 22(2):162-9. PubMed ID: 12085417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
    Zheng M; Lv LL; Cao YH; Zhang JD; Wu M; Ma KL; Phillips AO; Liu BC
    Clin Endocrinol (Oxf); 2012 May; 76(5):657-64. PubMed ID: 21824169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.